Laser boost for stubborn psoriasis on hands and feet

NCT ID NCT07713212

Not yet recruiting Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study compares two treatments for palmoplantar psoriasis, a form of psoriasis affecting the palms and soles. One group receives a topical steroid cream alone, while the other receives the same cream plus a fractional CO2 laser treatment every four weeks. The goal is to see if the laser helps the steroid work better, improving skin clearance and reducing severity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fractional CO2 laser and topical corticosteroid
What this could lead to: If successful, this approach could offer a more effective treatment option for stubborn palmoplantar psoriasis.
What could go wrong: This is a small pilot study, so results may not apply broadly. The laser adds cost and potential side effects like pain or scarring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PALMOPLANTAR PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

palmoplantar pustulosis psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIASIS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cairo University

Cairo, Cairo Governorate, 11562, Egypt

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.